USPTO serial 87171470
GLOBAL BIOMEDIA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARESCA, MEREDITH Z
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with GLOBAL BIOMEDIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pollie Gautsch
POLLIE GAUTSCH G&A LEGAL, APC665 SAN RODOLFO 124-209SOLANA BEACH, CA 92075UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents, namely, a solution used for scientific and medical research purposes for handling of mammalian cells which keeps cells disaggregated, round and stopped in a stabile state while stabilizing membranes, membrane markers, membrane receptors and cluster differentiation (CD) markers; eukaryotic cell culture reagents, namely, a solution that contains enzymes for detaching and disassociating attached mammalian cell culture from the growth substrates for scientific research use or medical research use; Chemical preparations for scientific and medical research use, namely, sterile solutions that keeps dissociated eukaryotic cells round and unattached for long periods of time and blocks attachment to plastic surfaces for scientific and medical research purposes; chemical preparations for scientific and medical laboratory use, namely, a chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells, except for medical or veterinary use | ACTIVE | — |
| 005 | Organ preservation solutions for medical transplant use, namely, storage and preservation solution for machine perfusion of animal and human organs, tissues, and cells, specifically kidneys, abdominal organs and tissues, thoracic organs and tissues, and stem cells, for the purpose of transplantation; Nutrient-based solutions for medical use to store and treat cells, tissues, and organs in order to sustain life-providing systems, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues, and organs while preventing or slowing their death; Organ preservation solutions for medical transplant use, namely, a static, hypothermic, flushing, transport, and storage solution for animal and human organs, tissues, and cells, specifically whole hearts, heart tissue, cardiomyocytes, and stem cells, for the purpose of transplantation; Organ preservation solutions for medical transplant use, namely, storage and preservation solution for donor animal tissues and organs for the purpose of transplantation and for use in long-term mesothermic machine perfusion and ex-vivo healing and repair of tissues and organs; cell culture media for medical and veterinary use, namely, protein-free media for growing cells in biomedical and mammalian cell culture applications; Nutrient-based solutions for medical use in applications which require the support of life-providing systems in cells, tissues and organs, namely, solutions composed of complex mixtures of the nutrients required to support the normal cellular biochemistry and physiology, ex-vivo or in vitro, of living cells, tissues and organs while preventing or slowing their death; Nutritive substances for microorganism cultures for medical use, namely, a production boosting chemical solution for increasing recombinant protein or monoclonal antibody production from cultures of mammalian cells; Medical transplant solutions, namely, cornea preservation solutions used to aid in the flushing, transporting, storing, and preserving of animal corneas, eye tissues, eye cells, and stem cells for medical transplants | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 20, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 22, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2016 | NWAP | NEW APPLICATION ENTERED | — |